Insider: Schuetz Thomas J. CHIEF EXECUTIVE OFFICER - Compass Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 6,480,825 | 0 | 6,480,825 |
| Value | $35,320,496.25 | $0.00 | $35,320,496.25 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 05/27/2025 | AAP | 10,000 | Direct | COM | $2.11 | $21,100.00 | 6,480,825 |
| 03/10/2023 | AAP | 10,000 | Direct | COM | $3.37 | $33,700.00 | 6,021,873 |
| 02/27/2023 | AAP | 20,000 | Direct | COM | $3.98 | $79,600.00 | 6,011,873 |
| 02/15/2023 | AAP | 20,000 | Direct | COM | $3.86 | $77,200.00 | 5,991,873 |
| 01/31/2023 | AAP | 20,000 | Direct | COM | $4.05 | $81,000.00 | 5,471,873 |
| 01/24/2023 | AAP | 20,000 | Direct | COM | $4.19 | $83,800.00 | 5,451,873 |
| 09/28/2022 | AAP | 10,000 | Direct | COM | $2.32 | $23,200.00 | 5,431,873 |
| 09/26/2022 | AAP | 15,000 | Direct | COM | $2.27 | $34,050.00 | 5,421,873 |
| 09/07/2022 | AAP | 15,000 | Direct | COM | $3.03 | $45,450.00 | 5,406,873 |
| 09/01/2022 | AAP | 15,000 | Direct | COM | $2.83 | $42,450.00 | 5,391,873 |
| 08/17/2022 | AAP | 15,000 | Direct | COM | $3.05 | $45,750.00 | 5,376,873 |
| 08/10/2022 | AAP | 15,000 | Direct | COM | $2.64 | $39,600.00 | 5,361,873 |
| 08/01/2022 | AAP | 15,000 | Direct | COM | $2.58 | $38,700.00 | 5,346,873 |
| 06/13/2022 | AAP | 30,000 | Direct | COM | $2.29 | $68,700.00 | 5,291,873 |
| 06/06/2022 | AAP | 30,000 | Direct | COM | $2.83 | $84,900.00 | 5,261,873 |
| 06/01/2022 | AAP | 20,000 | Direct | COM | $3.03 | $60,600.00 | 5,231,873 |
| 05/26/2022 | AAP | 20,000 | Direct | COM | $3.04 | $60,800.00 | 5,211,873 |
| 05/23/2022 | AAP | 18,355 | Direct | COM | $2.72 | $49,925.60 | 5,191,873 |
| 05/17/2022 | AAP | 20,215 | Direct | COM | $2.47 | $49,931.05 | 5,173,518 |
| 05/10/2022 | AAP | 27,836 | Direct | COM | $1.80 | $50,104.80 | 5,153,303 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research